Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157522393> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2157522393 endingPage "540" @default.
- W2157522393 startingPage "532" @default.
- W2157522393 abstract "Burkitt lymphoma (BL) accounts for 50% of childhood cancer in Malawi. Lack of resources precludes the use of new successful treatment approaches such as the LMB 89 group B protocol, which cures >80% of children with stage III BL with high dose chemotherapy and matching supportive care. Our objective was to achieve a good cure rate in Murphy stage I-III BL with manageable toxicity in Malawi at a drug cost of <1000 US dollars per patient.The intensity and toxicity of the LMB 89 group B protocol was reduced and adapted to Malawi realities. All stages received the same treatment. Children with suspected BL in the period July 1997-November 1999 were subjected to abdominal ultrasound, a tumor biopsy and/or fine needle aspirate (FNA) and bone marrow (BM), cerebrospinal fluid (CSF), and peripheral blood examination. HIV seropositive children were excluded. Endpoints are projected event free survival (EFS) at minimum 1 year, blood and gastro-intestinal tract toxicity, and risk for and severity of infections.Forty-four children were eligible for treatment and analysis. Their median age was 7.2 years, M:F ratio 1.4:1 with 10 stage I, 5 stage II, and 29 stage III patients. Projected Kaplan-Meier EFS for all was 57% (CI 41-73) at 1 year with 90% EFS in stage I and 52% EFS in stage III. The survival curve remained stable at 500 days. Toxicity and delays in appropriate supportive care contributed to ten deaths during treatment. Local recurrent tumor caused five and CNS recurrence one death. Two children died from progressive disease. The incidence of severe (grade 3 and/or 4) hematologic toxicity varied from 13% to 36%, gastro-intestinal toxicity (GIT) from 2% to 17%, and infections from 7% to 41% per chemotherapy module.It is possible to administer less intense and less costly multiagent chemotherapy to children with BL in a developing society with acceptable EFS rates. Adequate supportive care of the at-times associated severe toxicity must be made available to better the results." @default.
- W2157522393 created "2016-06-24" @default.
- W2157522393 creator A5013707835 @default.
- W2157522393 creator A5015265696 @default.
- W2157522393 creator A5042138962 @default.
- W2157522393 creator A5046518918 @default.
- W2157522393 creator A5053824151 @default.
- W2157522393 creator A5056757114 @default.
- W2157522393 creator A5062973431 @default.
- W2157522393 creator A5082715224 @default.
- W2157522393 date "2003-10-24" @default.
- W2157522393 modified "2023-10-11" @default.
- W2157522393 title "Malawi pilot study of Burkitt lymphoma treatment" @default.
- W2157522393 cites W1980938438 @default.
- W2157522393 cites W2069455563 @default.
- W2157522393 cites W2077204492 @default.
- W2157522393 cites W2093744470 @default.
- W2157522393 cites W2116294628 @default.
- W2157522393 cites W2156073127 @default.
- W2157522393 doi "https://doi.org/10.1002/mpo.10322" @default.
- W2157522393 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14595710" @default.
- W2157522393 hasPublicationYear "2003" @default.
- W2157522393 type Work @default.
- W2157522393 sameAs 2157522393 @default.
- W2157522393 citedByCount "71" @default.
- W2157522393 countsByYear W21575223932012 @default.
- W2157522393 countsByYear W21575223932013 @default.
- W2157522393 countsByYear W21575223932014 @default.
- W2157522393 countsByYear W21575223932015 @default.
- W2157522393 countsByYear W21575223932016 @default.
- W2157522393 countsByYear W21575223932017 @default.
- W2157522393 countsByYear W21575223932018 @default.
- W2157522393 countsByYear W21575223932019 @default.
- W2157522393 countsByYear W21575223932020 @default.
- W2157522393 countsByYear W21575223932021 @default.
- W2157522393 countsByYear W21575223932022 @default.
- W2157522393 countsByYear W21575223932023 @default.
- W2157522393 crossrefType "journal-article" @default.
- W2157522393 hasAuthorship W2157522393A5013707835 @default.
- W2157522393 hasAuthorship W2157522393A5015265696 @default.
- W2157522393 hasAuthorship W2157522393A5042138962 @default.
- W2157522393 hasAuthorship W2157522393A5046518918 @default.
- W2157522393 hasAuthorship W2157522393A5053824151 @default.
- W2157522393 hasAuthorship W2157522393A5056757114 @default.
- W2157522393 hasAuthorship W2157522393A5062973431 @default.
- W2157522393 hasAuthorship W2157522393A5082715224 @default.
- W2157522393 hasConcept C126322002 @default.
- W2157522393 hasConcept C141071460 @default.
- W2157522393 hasConcept C146357865 @default.
- W2157522393 hasConcept C151730666 @default.
- W2157522393 hasConcept C2775934546 @default.
- W2157522393 hasConcept C2776694085 @default.
- W2157522393 hasConcept C2779338263 @default.
- W2157522393 hasConcept C29730261 @default.
- W2157522393 hasConcept C71924100 @default.
- W2157522393 hasConcept C86803240 @default.
- W2157522393 hasConcept C90924648 @default.
- W2157522393 hasConceptScore W2157522393C126322002 @default.
- W2157522393 hasConceptScore W2157522393C141071460 @default.
- W2157522393 hasConceptScore W2157522393C146357865 @default.
- W2157522393 hasConceptScore W2157522393C151730666 @default.
- W2157522393 hasConceptScore W2157522393C2775934546 @default.
- W2157522393 hasConceptScore W2157522393C2776694085 @default.
- W2157522393 hasConceptScore W2157522393C2779338263 @default.
- W2157522393 hasConceptScore W2157522393C29730261 @default.
- W2157522393 hasConceptScore W2157522393C71924100 @default.
- W2157522393 hasConceptScore W2157522393C86803240 @default.
- W2157522393 hasConceptScore W2157522393C90924648 @default.
- W2157522393 hasIssue "6" @default.
- W2157522393 hasLocation W21575223931 @default.
- W2157522393 hasLocation W21575223932 @default.
- W2157522393 hasOpenAccess W2157522393 @default.
- W2157522393 hasPrimaryLocation W21575223931 @default.
- W2157522393 hasRelatedWork W1988477118 @default.
- W2157522393 hasRelatedWork W2005585032 @default.
- W2157522393 hasRelatedWork W2088620963 @default.
- W2157522393 hasRelatedWork W2170271130 @default.
- W2157522393 hasRelatedWork W2329386257 @default.
- W2157522393 hasRelatedWork W2397320258 @default.
- W2157522393 hasRelatedWork W2402743643 @default.
- W2157522393 hasRelatedWork W4313063054 @default.
- W2157522393 hasRelatedWork W4324058133 @default.
- W2157522393 hasRelatedWork W648618910 @default.
- W2157522393 hasVolume "41" @default.
- W2157522393 isParatext "false" @default.
- W2157522393 isRetracted "false" @default.
- W2157522393 magId "2157522393" @default.
- W2157522393 workType "article" @default.